Decision Analytic Modeling: Some Uses in the Evaluation of New Pharmaceuticals
- 1 July 1994
- journal article
- research article
- Published by Springer Nature in Drug Information Journal
- Vol. 28 (3), 691-707
- https://doi.org/10.1177/009286159402800306
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- A Model for Evaluating the Cost-Effectiveness of Cholesterol-Lowering TreatmentInternational Journal of Technology Assessment in Health Care, 1992
- Cost-effectiveness of HA-1A Monoclonal Antibody for Gram-Negative SepsisPublished by American Medical Association (AMA) ,1991
- An updated coronary risk profile. A statement for health professionals.Circulation, 1991
- Reducing High Blood Cholesterol Level With DrugsPublished by American Medical Association (AMA) ,1990
- The Value of Lowering Cholesterol after Myocardial InfarctionNew England Journal of Medicine, 1990
- Getting to the Heart of the Cholesterol DebateScience, 1990
- Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with DyslipidemiaNew England Journal of Medicine, 1987
- The Lipid Research Clinics Coronary Primary Prevention Trial ResultsJAMA, 1984
- The Markov Process in Medical PrognosisMedical Decision Making, 1983
- Comparative reproducibility and validity of systems for assessing cardiovascular functional class: advantages of a new specific activity scale.Circulation, 1981